Antiviral drug Codivir, developed by Code Pharma BV, shows promising effect against COVID-19, wrote AP News. Codivir, a short synthetic 16 amino-acid peptide derived from the HIV-1 integrase, was initially discovered at the Hebrew University in Israel.
These results indicate that the drug can be used to treat COVID-19 patients suffering at different levels of severity. Due to its direct antiviral effect, Codivir may have a similar beneficial effect on other RNA viruses, such as influenza.
Code Pharma founder and CEO, Zyon Ayni, said: “The drug works on the entire RNA virus family, a large assemblage of viruses and not just COVID-19. The drug is the world’s next hope for a complete cure for the virus”.
